| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 1/2 | |||
| NCT02503423 | Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas | Solid Tumors | Active, Not Recruiting |
| Phase 1 | |||
| NCT05082259 | ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab | Advanced Cancer | Recruiting |
| NCT05403450 | A Study of Tolinapant in Combination With Oral Decitabine/Cedazuridine and Oral… | Relapsed/Refractory Peripheral T-cell Lymphoma | Active, Not Recruiting |
| Early Phase 1 | |||
| NCT05245682 | Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced… | Head and Neck Carcinoma of Unknown Primary | Active, Not Recruiting |